Podiatrists in Kennesaw, GA Accepting Medicare

8 Podiatrists found. Showing 1 - 8

Erin Jeannine Cupolo, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5205 Stilesboro Rd Nw Ste 205, Kennesaw, GA 30152 Phone: 678-310-0540    Fax: 678-310-0538

Miller Foot & Ankle Healthcare Inc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 3450 Acworth Due West Rd Nw, Suite 320, Kennesaw, GA 30144 Phone: 770-386-1234    Fax: 678-574-5549

Georgia Podiatry, Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 5205 Stilesboro Rd Nw Ste 205, Kennesaw, GA 30152 Phone: 678-310-0540    Fax: 678-310-0538

Dr. Michael Wade Dixon, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 440 Ernest W Barrett Pkwy Nw, Ste 62, Kennesaw, GA 30144 Phone: 770-422-0280    Fax: 770-426-5388

Cobb Podiatry, P.c. Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 921 Checkered Way Nw, Kennesaw, GA 30152 Phone: 770-596-2376    Fax: 773-940-4820

Evan M Brody, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5205 Stilesboro Rd Nw Ste 205, Kennesaw, GA 30152 Phone: 678-310-0540    Fax: 678-310-0538

Barrett Parkway Foot And Leg Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 440 Ernest W Barrett Pkwy Nw, Ste 62, Kennesaw, GA 30144 Phone: 770-042-2028    Fax: 770-426-5388

Harshil Patel Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 5205 Stilesboro Rd Nw Ste 205, Kennesaw, GA 30152 Phone: 678-310-0540    Fax: 678-310-0538

News Archive

Teva Pharmaceutical launches Fexofenadine HCl and Pseudoephedrine HCl tablets

Teva Pharmaceutical Industries Ltd. announced today the commercial launch of Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D® 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets. Teva's product is an alternative to the brand product, which had annual sales of approximately $293 million in the United States for the twelve months that ended June 30, 2009, based on IMS sales data.

Good health helps children with stressful elementary to middle school transitions

Good health helps children with stressful transitions from elementary school to middle school, finds a new study in the Journal of Adolescent Health. Students with chronic conditions such as asthma, obesity, learning disabilities, attention-deficit hyperactivity disorder, and those with health-related needs, were noted to have lower academic performances.

Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research, has found that when antiretroviral therapy (ART) is initiated during early acute HIV infection, it can significantly reduce total HIV DNA levels in the body, which may have implications for the goal of achieving long-term HIV remission.

On-duty firefighters more likely to be exposed to potentially harmful chemicals

A new Oregon State University study suggests that firefighters are more likely to be exposed to potentially harmful chemicals while on duty compared to off duty.

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Mesothelioma.us, an educational and authoritative website that offers free and in-depth resources for mesothelioma patients and their families, has just released a new case study that focuses on the experimental treatments for the disease.

Read more Medical News

› Verified 8 days ago